Tag Archive for: pediatric cancer

The European Union and the United States have launched a new joint health task force to cooperate on cancer, global health threats and related supply chains and infrastructure, officials told a press conference today.

The company was seeking approval of omburtamab to treat a rare form of nerve cancer in pediatric patients. The FDA’s decision follows a unanimous vote in October against the drug to treat neuroblastoma due to insufficient evidence that it improves overall survival.

September is Childhood Cancer Awareness Month, which sheds light on the need for new developments in pediatric oncology. For American children, the number one cause of death by disease is cancer. Pediatric gliomas, the most common type of brain tumor in children, are a critical area of focus for oncology research.

The U.S. Food and Drug Administration has approved Fennec Pharmaceuticals Inc.’s intravenous therapy to prevent chemotherapy-induced hearing loss in children, according to the health regulator’s website.

An oral drug combination by Swiss pharmaceuticals company Novartis (NOVN.S) showed promise in treating a subgroup of patients suffering from a common childhood brain cancer in a trial.